Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
A grandfather and grandson hugging

Our purpose


Reimagine medicine to improve and extend
people's lives.

A family standing outside looking into the sunset

Our vision
 

Become the most valued and trusted medicines company in the world.

Group of women from an indigenous community at a health workshop near Santa Cecilia, Colombia

Our strategy
 

Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Our footprint

78k

Employees*

130

Countries**

250m+

Patients reached***

We focus on core therapeutic areas with high unmet patient needs

HCP and patient interacting using a tablet

Cardiovascular, renal and metabolic

Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases.
HCP taking patient's blood pressure

Immunology

Working to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
Nurse and patient exchanging a warm moment

Neuroscience

Committed to change the course of disease progression in neuroscience.
Doctor and patient interacting over medical results

Oncology

Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.

and technology platforms that enable cutting-edge innovative therapies

Blue gradient icon of a flask

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.

Blue gradient icon of an antibody

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.

Blue gradient icon of a seringue

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.

Blue gradient icon of an atom

Radioligand therapy

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.

Blue gradient icon of a gene

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.


 

In this new era, we’re ready.
Together, let’s reimagine medicine to improve and extend people’s lives.

 

Resource links

Pipeline
Impact
Leadership

*Based on 2022 data except for employees which has been restated to exclude Sandoz
** Based on 2022 data, excluding Sandoz
*** Based on 2022 data, excluding Sandoz: 236 million patients reached with innovative medicines; 54 million patients reached through Novartis Global Health, which focuses on transforming health in low- and middle-income countries.